Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
Fawzy AM, Rivera-Caravaca JM, Underhill P, et al.
Diabetes Obes Metab. 2023;25(2):602-610.
Leggi